GBT Announces Participation at the Goldman Sachs 41st Annual Global Healthcare Conference Webcast
June 02 2020 - 8:00AM
Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced
that it will present at the Goldman Sachs 41st Annual Global
Healthcare Conference Webcast on Tuesday, June 9, 2020, at 3:50
p.m. Eastern Time.
The presentation will be webcast live from GBT’s website at
www.gbt.com in the Investors section. A replay of the webcast will
be archived and available for one month following the event.
About Global Blood TherapeuticsGlobal Blood
Therapeutics (GBT) is a biopharmaceutical company dedicated to the
discovery, development and delivery of life-changing treatments
that provide hope to underserved patient communities. Founded in
2011, GBT is delivering on its goal to transform the treatment and
care of sickle cell disease (SCD), a lifelong, devastating
inherited blood disorder. The company has introduced Oxbryta®
(voxelotor), the first FDA-approved treatment that directly
inhibits sickle hemoglobin polymerization, an underlying cause of
SCD. GBT is also advancing its pipeline program in SCD with
inclacumab, a p-selectin inhibitor in development to address pain
crises associated with the disease. In addition, GBT’s drug
discovery teams are working on new targets to develop the next
generation of treatments for SCD. To learn more, please visit
www.gbt.com and follow the company on Twitter @GBT_news.
Contact Information:Steven Immergut
(media)650-410-3258simmergut@gbt.com
Stephanie Yao (investors)650-741-7730syao@gbt.com
Global Blood Therapeutics (NASDAQ:GBT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Global Blood Therapeutics (NASDAQ:GBT)
Historical Stock Chart
From Apr 2023 to Apr 2024